Difluprednate 0.05% twice a day vs prednisolone acetate 1% 4 times a day for cataract postsurgical inflammation treatment: noninferiority trial

Volume: 48, Issue: 7, Pages: 753 - 758
Published: Jul 1, 2022
Abstract
To establish whether difluprednate 0.05% nanoemulsion (DIFL) twice a day is as effective as prednisolone acetate 1% + phenylephrine hydrochloride 0.12% suspension (PRED) 4 times a day for postsurgical inflammation treatment.4 private Argentine ophthalmological centers.Noninferiority, prospective, multicenter, double-blind, randomized, parallel-group, comparative trial.A total of 259 patients who underwent phacoemulsification randomly received...
Paper Details
Title
Difluprednate 0.05% twice a day vs prednisolone acetate 1% 4 times a day for cataract postsurgical inflammation treatment: noninferiority trial
Published Date
Jul 1, 2022
Volume
48
Issue
7
Pages
753 - 758
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.